SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-013121
Filing Date
2006-03-01
Accepted
2006-03-01 15:24:11
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-2031_110k.htm 10-K 1413608
2 CONSENTS OF EXPERTS AND COUNSEL a06-2031_1ex23d1.htm EX-23.1 4683
3 302 CERTIFICATION a06-2031_1ex31d1.htm EX-31.1 12255
4 302 CERTIFICATION a06-2031_1ex31d2.htm EX-31.2 12123
5 906 CERTIFICATION a06-2031_1ex32d1.htm EX-32.1 5925
6 906 CERTIFICATION a06-2031_1ex32d2.htm EX-32.2 5111
  Complete submission text file 0001104659-06-013121.txt   1455151
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16614 | Film No.: 06655321
SIC: 2835 In Vitro & In Vivo Diagnostic Substances